美國Seracare大腸桿菌O91陽性對照

廣州健侖生物科技有限公司

廣州健侖長期供應各種生物原料，主要代理品牌：美國Seracare、西班牙Certest、美國Fuller等等。

主要產品包括各種標準品、陽性對照品、陽性質控品、單克隆抗原抗體。

其中常見的有：弓形蟲病、西尼羅河病毒、類風濕因子、瘧疾、麻疹、萊姆病、百日咳桿菌、大腸桿菌、鼠傷寒沙門氏菌、李斯特菌等陽性對照品。

美國Seracare大腸桿菌O91陽性對照

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

歡迎咨詢

歡迎咨詢2042552662

【Seracare產品介紹】

美國Seracare

Müller 及其同事發現，從GBM患者血液中所取樣的循環腫瘤細胞要比在這些病人中預計發現的顱外腫瘤數多得多。他們沒有發現對顱腦腫瘤動手術會增加腫瘤細胞在其它地方循環的任何證據。
在一篇相關的《焦點》文章中，Lara Perryman和Janine Erler提出，對GBM患者血液做循環腫瘤細胞篩檢可幫助確定哪些病人可能成為合適的器官捐贈者。他們提示，這些循環細胞還可被用作一種監測該腦腫瘤進展與治療的新方法。
多數細胞不能分裂，除非有足夠的氧氣存在以支持它們的后代，但是某些癌細胞和其他細胞類型規避了這個規則?，F在，美國約翰霍普金斯大學的研究人員鑒定出廢除細胞警告信號的機制，使得癌細胞能夠繼續分裂即使在沒有強大的血液供給條件下。在這個過程中，研究人員發現溶酶體——細胞的蛋白質‘重復利用中心’——幫助控制細胞分裂的決定。他們還發現了新的證據表明某些藥物能夠停止腫瘤的生長，具有高水平的蛋白HIF-1α。
低水平氧氣促進HIF-1α的產生與活化，它以兩種方式保護細胞。首先，它開啟一些基因產生蛋白幫助細胞適應氧氣不足。它也能停止DNA復制，防止細胞分裂并增加更多需氧細胞到一個已經很惡劣的環境中。
了解某些細胞忽略HIF-1α的警告并且繼續分裂，Gregg Semenza博士及其團隊尋找HIF-1α與Cdk1、Cdk2之間的關系，這一蛋白已知調節細胞分裂的決定。他們發現HIF-1α與兩者可以相互作用，但是Cdk1增加HIF-1α水平，而Cdk2減低HIF-1α水平。
Semenza的團隊懷疑Cdk1與Cdk2按照HIF-1α的指示行事通過細胞的微型“垃圾處理器”稱為蛋白酶體標記或者不標記毀滅。但是，當研究人員限制蛋白酶體的功能后，他們發現并沒有改變HIF-1α的水平。相反，結果證明是Cdk1與Cdk2通過細胞的溶酶體標記或者不標記毀滅改變了HIF-1α水平。就他們所知，這是*次發現溶酶體牽涉到細胞的分裂決定中。
值得注意的是，在某些腫瘤細胞中，Cdk2能夠增加HIF-1α的水平同時也刺激其基因激活作用。有效效應是細胞連續分裂同時應付低氧水平。在培養的細胞中，藥物抑制Cdk1以防止HIF-1α水平的下降，并且恢復停止細胞分裂的能力，揭示它們也許能有效治療某些腫瘤。

美國Seracare

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、食品安全、化妝品檢測、藥物濫用檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

想了解更多的產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

Müller and colleagues found that circulating tumor cells sampled from the blood of GBM patients were much more numerous than the extracranial tumors expected to be found in these patients. They found no evidence that cranial brain surgery would increase the circulation of tumor cells elsewhere.
In a related Focus article, Lara Perryman and Janine Erler suggest that circulating tumor cell screening of GBM patients' blood can help determine which patients may be suitable organ donors. They suggest that these circulating cells may also be used as a new method of monitoring the progress and treatment of this brain tumor.
Most cells can not divide unless certain oxygen is present to support their offspring, but some cancers and other cell types circumvent this rule. Now, researchers at Johns Hopkins University in the United States have identified a mechanism to abolish cellular warning signals so that cancer cells can continue dividing even without a strong blood supply. In the process, researchers found that lysosomes - the cellular protein 'recycle center' - helped to control cell division. They also found new evidence that certain drugs stop tumor growth and have high levels of protein HIF-1α.
Low levels of oxygen promote HIF-1α production and activation, which protects cells in two ways. First, it turns on some gene-producing proteins to help cells adapt to oxygen deficiency. It also stops DNA replication, prevents cell division and adds more aerobic cells to an already harsh environment.
Knowing some cells ignore the warning of HIF-1α and continue to divide, Dr. Gregg Semenza and his team looked for a relationship between HIF-1α and Cdk1, Cdk2, a protein known to regulate cell division. They found that HIF-1α interacted with both, but Cdk1 increased HIF-1α levels and Cdk2 decreased HIF-1α levels.
Semenza's team suspects that Cdk1 and Cdk2, acting on HIF-1α's targets, are called proteasome tags or unmarked annihilation through the cells' tiny "garbage disposers." However, when researchers limited proteasome function, they found that they did not alter HIF-1α levels. Conversely, the results demonstrate that altering HIF-1Î ± levels by lysosomal or unlabeled destruction of Cdk1 and Cdk2 by cells. To the best of their knowledge, this is the first discovery that lysosomes are involved in cell division decisions.
It is noteworthy that in some tumor cells, Cdk2 can increase the level of HIF-1α and also stimulate its gene activation. The effective effect is the continuous division of cells while dealing with hypoxia levels. In cultured cells, the drug inhibits Cdk1 to prevent a decrease in HIF-1α levels and resumes its ability to stop cell division, revealing that they may be effective in treating certain tumors.